With our 'Healixia Academy', we offer a range of highly educational and qualitative sessions, both cross-domain and domain specific. With a mix of advanced courses (1 - 2 days), conferences en shorter (online) sessions on a variety of topics, we help our members in their professional growth. Want to know more? Have a look at what Healixia Academy offers throughout the year.
Select your domain(s)
15 December '22
Healixia online conference: Medical Devices
This training course is intended for both manufacturers and distributors of medical devices/ in vitro medical devices and will address various questions/issues under the MDR/IVDR.
27 January '23
Healixia seminar: From CTD to CTR - How to keep Belgium attractive for early phase development in EUDiegem
From January 2023 onwards all clinical trial applications, including phase 1 trials, need to be submitted according to the new Clinical Trial Regulation (CTR). In this meeting, all stakeholders are brought together and given the opportunity to express their perceived challenges and opportunities as we move into this new legislative framework.
02 February '23
Healixia New Year's EventAntwerpen (Wilrijk)
Join us for an inspirational talk and a networking drink to kick off 2023!
Keynote: Wellbeing is key for business succes, by Gert Braeken, author of 'Het burn-outvaccin'.
03 March '23
Healixia lunchmeeting: Value Based Healthcare
Speakers: Prof. Dr. Jo Lambert (UZ Gent) and Prof. Brecht Cardoen (Vlerick Business School)
More information will follow soon!
16 December '22
EUFEMED webinar - Christmas lecture: The (early) clinical development of new analgesics: the point of view of a pain clinician.
EUFEMED invites you to their fourth and last 2022 EUFEMED webinar.
13 March '23
AFPT - Training 2023
AFPT-Le Club Phase 1/EUFEMED/Université Paris-Saclay course: “Pre-Clinical and Clinical Safety in Early Development Human Trials”
This course addresses postgraduates in life sciences interested in early clinical development of medicinal products. The training of several days provides a concise overview on safety in Human Pharmacology / Translational Medicine spanning from non-clinical pharmacology and toxicology over first-in-man to proof-of-concept clinical trials.